Decreased serum levels of IL‐17 and TGF‐β were mainly in the early tumor stages which can be related to the inhibitory role of chemoradiotherapy on Th17 cells and TGF‐β‐producing tumor cells. This evidence concerns the gene TGFB1 and neoplasm.